Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-23

Clinical Trial Update: The Effect of Reduced Bleomycin in Electrochemotherapy Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating reduced bleomycin in electrochemotherapy for cutaneous metastases and cutaneous malignant mixed tumors; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bleomycin (bleomycin)

Snippet

Sponsor: Julie Gehl | Conditions: Cutaneous Metastasis, Cutaneous Malignant Mixed Tumor | Phase 4 | Status: RECRUITING